The epidemiology of Malassezia pachydermatis is the study of the distribution and determinants of this yeast in different populations and environments. A zoophilic yeast called Malassezia pachydermatis typically dwells on the skin and ears of animals but can also cause infections in humans, especially neonates and immunocompromised patients.
Some of the factors that influence the epidemiology of Malassezia pachydermatis are:
The host species and their geographic location, Malassezia pachydermatis, has been isolated from various animals, such as dogs, cats, rhinoceroses, sea lions, and black bears. The prevalence and diversity of this yeast may vary depending on the animal species and their habitat. For example, a study found that M. pachydermatis was more prevalent and diverse in brown bears from Italy than in Finland.
The host’s health status and immune system Malassezia pachydermatis can cause opportunistic infections in hosts with impaired skin barrier function or immune system. It can be due to prematurity, malnutrition, malignancy, chemotherapy, organ transplantation, or HIV infection. Using intravenous lipid supplementation or parenteral nutrition via a catheter can also increase the risk of infection by providing a source of lipids for the yeast to grow and invade the bloodstream.
The transmission mode and environmental factors Malassezia pachydermatis can be spread from one animal to another, from an animal to a human, or from a human to another human. The transmission can occur through direct contact, indirect contact via fomites or vectors, or airborne dissemination. The growth and colonisation of this yeast on the skin can also be impacted by environmental variables including temperature, humidity, sebum production, or lipid content.
The molecular epidemiology of Malassezia pachydermatis is the study of the genetic variation and evolution of this yeast among different hosts and environments. Molecular typing methods such as intergenic-spacer 1 (IGS1) nucleotide sequence polymorphisms analysis or whole-genome sequencing it possible to determine the genotypes & subtypes of M. pachydermatis isolates and to investigate their phylogenetic relationships, clonal structure, and population dynamics.
Molecular epidemiology can help to understand the origin, spread, and transmission of M. pachydermatis infections and outbreaks in different settings, such as neonatal intensive care units (NICUs), veterinary clinics, or wildlife reserves. Molecular epidemiology can also help to identify potential risk factors, reservoirs, or sources of infection and to implement appropriate prevention and control measures.
Classification and Structure
Kingdom: Fungi
Phylum: Basidiomycota
Class: Malasseziomycetes
Order: Malasseziales
Family: Malasseziaceae
Genus:Malassezia
Species:M. pachydermatis
The structure of Malassezia pachydermatis can be summarized in five points as follows:
Shape and Lipid Dependency: Malassezia pachydermatis is a bottle-shaped yeast that does not depend on lipids for growth (non-lipid dependent).
Colony Characteristics: Colonies of Malassezia pachydermatis are typically cream or yellowish. They have a smooth to wrinkled texture and a convex shape with a slightly lobed margin.
Cell Shape and Size: The cells of Malassezia pachydermatis are ovoid (egg-shaped) in shape and have a size range of approximately 3.0–6.5 x 2.5 micrometers (μm).
Reproductive Mode: Colonies of Malassezia pachydermatis grow through unipolar budding, and the presence of hyphae (thread-like structures) in culture is rare.
Optimal Growth Conditions: The yeast species thrives at a temperature range of 30–37 °C, and it typically takes about five days for maturation to occur under these conditions
M. pachydermatis has been reported to have different antigenic types based on its cell wall composition and immunological properties. A study by Bond et al. (1995) identified four antigenic types of M. pachydermatis (A, B, C, and D) by using monoclonal antibodies and enzyme-linked immunosorbent assay (ELISA).
Another study by Bond et al. (1996) found that antigenic type A was the most prevalent among clinical isolates from dogs with otitis externa and dermatitis, followed by types B, C, and D. Antigenic type A was also associated with higher levels of phospholipase activity, which is an enzyme that can damage the host’s cell membranes.
More recently, a study by Cafarchia et al. (2013) used molecular methods to investigate the genetic diversity and antigenic types of M. pachydermatis from different animal hosts, including dogs, cats, horses, rabbits, bears, and bats. They found that M. pachydermatis had a high degree of genetic variability and could be divided into 12 genotypes based on the rDNA’s internal transcribed spacer (ITS) region.
They also found that the antigenic types A, B, C, and D corresponded to four main genotypes (I, II, III, and IV). In contrast, the other genotypes had mixed or undefined antigenic types. They suggested that the antigenic types of M. pachydermatis may reflect its adaptation to different hosts and environments.
Malassezia pachydermatis is a yeast that usually lives on the skin and ears of animals but can, in certain circumstances, infect humans. The pathogenesis of Malassezia pachydermatis related to humans is rare and mainly involves invasive infections in neonates or immunocompromised patients. Some of the factors that contribute to the pathogenesis are:
The use of intravenous lipid supplementation or parenteral nutrition via a catheter provides a source of lipids for the yeast to grow and invade the bloodstream.
A central venous catheter or other indwelling device is present. Endotracheal tubes, or peritoneal dialysis catheters, can act as a point of access for the yeast and cause biofilm formation.
The host immune system’s impairment can be due to prematurity, malnutrition, malignancy, chemotherapy, organ transplantation, or HIV infection.
The production of enzymes and metabolites by the yeast that damage the host tissues and cells, such as proteinase, phospholipase, hyaluronidase, and chondroitin-sulphatase.
Malassezia pachydermatis can cause septicemia, meningitis, endocarditis, peritonitis, pneumonia, and other systemic infections in humans. The diagnosis of Malassezia pachydermatis infection is based on clinical signs, blood culture, molecular methods, and histopathology.
The host defenses of Malassezia pachydermatis are the mechanisms the host’s immune system uses to protect itself from infection or colonization by this yeast. A commensal fungus called Malassezia pachydermatis typically dwells on the skin ofanimals, especially dogs, but can sometimes cause diseases such as otitis externa and dermatitis.
Some examples of innate defenses against Malassezia pachydermatis are:
Skin Barrier: The skin’s layers, including the tough epidermis with keratinocytes and melanocytes, act as a physical and chemical defense against microbial invasion.
Skin Microbiota: Diverse microorganisms on the skin create an ecosystem that competes with pathogens, produces antimicrobial substances, and influences the immune system.
Skin Immune System: Resident immune cells (e.g., Langerhans cells, macrophages) and recruited immune cells (e.g., neutrophils, lymphocytes) in the skin, along with various immune molecules recognize and respond to foreign invaders.
Some examples of adaptive defenses against Malassezia pachydermatis are:
Antigen-presenting cells (APCs), T cells, & B cells are used by the adaptive immune system to produce a targeted and persistent response to the yeast. APCs are immune cells that capture and process Malassezia pachydermatis antigens and present them to T cells. T cells are lymphocytes that differentiate into different subsets depending on the type of antigen and cytokine environment. T helper 1, T helper 17, & T helper 2 (Th1) are examples of T cell subsets, regulatory T (Treg), and cytotoxic T (Tc) cells. Th1 cells produce interferon-gamma (IFN-gamma) and activate macrophages to kill the yeast. Th2 cells produce interleukin-4 (IL-4) and IL-13, promoting B cell activation and antibody production. Th17 cells produce IL-17 and IL-22 and recruit neutrophils to the site of infection. Treg cells produce IL-10 and transforming growth factor-beta (TGF-beta), suppressing inflammation and tissue damage. Tc cells produce perforin and granzymes and directly kill infected cells. B cells are lymphocytes that produce antibodies that bind to Malassezia pachydermatis antigens and neutralize or opsonize them for phagocytosis.
Malassezia pachydermatis is a yeast that usually lives on the skin of animals, especially dogs, but can sometimes cause infections and diseases in humans. Some of the clinical manifestations of Malassezia pachydermatis related to humans are:
Fungemia: This is a bloodstream infection caused by M. pachydermatis, which in people with impaired immune systems can be fatal. It is frequently linked to the use of central venous catheters or intravenous infusions that contain lipids. Fever, chills, low blood pressure, and organ malfunction are possible symptoms.
Tinea versicolor: This benign skin condition caused by M. globosa, M. sympodialis, or M. furfur, closely related to M. pachydermatis. It is characterized by hypopigmented or hyperpigmented patches on the trunk, neck, arms, and face. The patches may be scaly, itchy, or asymptomatic.
Malassezia folliculitis: This is an inflammation of the hair follicles caused by Malassezia pachydermatis or another kind. It is manifested by pruritic papules and pustules on the chest, back, shoulders, arms, and face. It may resemble acne vulgaris or bacterial folliculitis.
Seborrheic dermatitis: This chronic inflammatory skin disorder affects the scalp, face, and chest. It is thought to be influenced by Malassezia species, including M. pachydermatis. It presents with erythema, scaling, and greasy, yellowish crusts on the affected areas. It may cause itching, burning, or irritation.
Malassezia pachydermatis can infect humans, particularly neonates and immunocompromised individuals. Diagnosis relies on clinical signs, blood culture (though limited), molecular methods like PCR, and histopathology. Clinical signs include fever, septic shock, respiratory distress, skin lesions, and organ dysfunction, but these are non-specific.
Blood culture is common but can be supplemented with molecular techniques for confirmation. Histopathology can visualize the yeast cells in tissues but can’t distinguish them from other fungi. Skin or ear samples can also be used but are less reliable for systemic infections.
Some general measures to control Malassezia pachydermatis infection are:
Removing or reducing the risk factors predisposing to infection, such as intravenous lipid supplementation, indwelling devices, immunosuppression, or skin barrier impairment.
Using topical or oral antifungal agents effective against Malassezia pachydermatis, such as ketoconazole, itraconazole, fluconazole, posaconazole, or amphotericin B.
Applying topical shampoos or creams that contain antifungal or anti-inflammatory ingredients, such as selenium sulfide, zinc pyrithione, coal tar, salicylic acid, or corticosteroids.
Cleaning and disinfecting the affected areas and avoiding scratching or rubbing.
Monitoring the clinical and microbiological response to treatment and adjusting the dose or duration of therapy accordingly.
The epidemiology of Malassezia pachydermatis is the study of the distribution and determinants of this yeast in different populations and environments. A zoophilic yeast called Malassezia pachydermatis typically dwells on the skin and ears of animals but can also cause infections in humans, especially neonates and immunocompromised patients.
Some of the factors that influence the epidemiology of Malassezia pachydermatis are:
The host species and their geographic location, Malassezia pachydermatis, has been isolated from various animals, such as dogs, cats, rhinoceroses, sea lions, and black bears. The prevalence and diversity of this yeast may vary depending on the animal species and their habitat. For example, a study found that M. pachydermatis was more prevalent and diverse in brown bears from Italy than in Finland.
The host’s health status and immune system Malassezia pachydermatis can cause opportunistic infections in hosts with impaired skin barrier function or immune system. It can be due to prematurity, malnutrition, malignancy, chemotherapy, organ transplantation, or HIV infection. Using intravenous lipid supplementation or parenteral nutrition via a catheter can also increase the risk of infection by providing a source of lipids for the yeast to grow and invade the bloodstream.
The transmission mode and environmental factors Malassezia pachydermatis can be spread from one animal to another, from an animal to a human, or from a human to another human. The transmission can occur through direct contact, indirect contact via fomites or vectors, or airborne dissemination. The growth and colonisation of this yeast on the skin can also be impacted by environmental variables including temperature, humidity, sebum production, or lipid content.
The molecular epidemiology of Malassezia pachydermatis is the study of the genetic variation and evolution of this yeast among different hosts and environments. Molecular typing methods such as intergenic-spacer 1 (IGS1) nucleotide sequence polymorphisms analysis or whole-genome sequencing it possible to determine the genotypes & subtypes of M. pachydermatis isolates and to investigate their phylogenetic relationships, clonal structure, and population dynamics.
Molecular epidemiology can help to understand the origin, spread, and transmission of M. pachydermatis infections and outbreaks in different settings, such as neonatal intensive care units (NICUs), veterinary clinics, or wildlife reserves. Molecular epidemiology can also help to identify potential risk factors, reservoirs, or sources of infection and to implement appropriate prevention and control measures.
Classification and Structure
Kingdom: Fungi
Phylum: Basidiomycota
Class: Malasseziomycetes
Order: Malasseziales
Family: Malasseziaceae
Genus:Malassezia
Species:M. pachydermatis
The structure of Malassezia pachydermatis can be summarized in five points as follows:
Shape and Lipid Dependency: Malassezia pachydermatis is a bottle-shaped yeast that does not depend on lipids for growth (non-lipid dependent).
Colony Characteristics: Colonies of Malassezia pachydermatis are typically cream or yellowish. They have a smooth to wrinkled texture and a convex shape with a slightly lobed margin.
Cell Shape and Size: The cells of Malassezia pachydermatis are ovoid (egg-shaped) in shape and have a size range of approximately 3.0–6.5 x 2.5 micrometers (μm).
Reproductive Mode: Colonies of Malassezia pachydermatis grow through unipolar budding, and the presence of hyphae (thread-like structures) in culture is rare.
Optimal Growth Conditions: The yeast species thrives at a temperature range of 30–37 °C, and it typically takes about five days for maturation to occur under these conditions
M. pachydermatis has been reported to have different antigenic types based on its cell wall composition and immunological properties. A study by Bond et al. (1995) identified four antigenic types of M. pachydermatis (A, B, C, and D) by using monoclonal antibodies and enzyme-linked immunosorbent assay (ELISA).
Another study by Bond et al. (1996) found that antigenic type A was the most prevalent among clinical isolates from dogs with otitis externa and dermatitis, followed by types B, C, and D. Antigenic type A was also associated with higher levels of phospholipase activity, which is an enzyme that can damage the host’s cell membranes.
More recently, a study by Cafarchia et al. (2013) used molecular methods to investigate the genetic diversity and antigenic types of M. pachydermatis from different animal hosts, including dogs, cats, horses, rabbits, bears, and bats. They found that M. pachydermatis had a high degree of genetic variability and could be divided into 12 genotypes based on the rDNA’s internal transcribed spacer (ITS) region.
They also found that the antigenic types A, B, C, and D corresponded to four main genotypes (I, II, III, and IV). In contrast, the other genotypes had mixed or undefined antigenic types. They suggested that the antigenic types of M. pachydermatis may reflect its adaptation to different hosts and environments.
Malassezia pachydermatis is a yeast that usually lives on the skin and ears of animals but can, in certain circumstances, infect humans. The pathogenesis of Malassezia pachydermatis related to humans is rare and mainly involves invasive infections in neonates or immunocompromised patients. Some of the factors that contribute to the pathogenesis are:
The use of intravenous lipid supplementation or parenteral nutrition via a catheter provides a source of lipids for the yeast to grow and invade the bloodstream.
A central venous catheter or other indwelling device is present. Endotracheal tubes, or peritoneal dialysis catheters, can act as a point of access for the yeast and cause biofilm formation.
The host immune system’s impairment can be due to prematurity, malnutrition, malignancy, chemotherapy, organ transplantation, or HIV infection.
The production of enzymes and metabolites by the yeast that damage the host tissues and cells, such as proteinase, phospholipase, hyaluronidase, and chondroitin-sulphatase.
Malassezia pachydermatis can cause septicemia, meningitis, endocarditis, peritonitis, pneumonia, and other systemic infections in humans. The diagnosis of Malassezia pachydermatis infection is based on clinical signs, blood culture, molecular methods, and histopathology.
The host defenses of Malassezia pachydermatis are the mechanisms the host’s immune system uses to protect itself from infection or colonization by this yeast. A commensal fungus called Malassezia pachydermatis typically dwells on the skin ofanimals, especially dogs, but can sometimes cause diseases such as otitis externa and dermatitis.
Some examples of innate defenses against Malassezia pachydermatis are:
Skin Barrier: The skin’s layers, including the tough epidermis with keratinocytes and melanocytes, act as a physical and chemical defense against microbial invasion.
Skin Microbiota: Diverse microorganisms on the skin create an ecosystem that competes with pathogens, produces antimicrobial substances, and influences the immune system.
Skin Immune System: Resident immune cells (e.g., Langerhans cells, macrophages) and recruited immune cells (e.g., neutrophils, lymphocytes) in the skin, along with various immune molecules recognize and respond to foreign invaders.
Some examples of adaptive defenses against Malassezia pachydermatis are:
Antigen-presenting cells (APCs), T cells, & B cells are used by the adaptive immune system to produce a targeted and persistent response to the yeast. APCs are immune cells that capture and process Malassezia pachydermatis antigens and present them to T cells. T cells are lymphocytes that differentiate into different subsets depending on the type of antigen and cytokine environment. T helper 1, T helper 17, & T helper 2 (Th1) are examples of T cell subsets, regulatory T (Treg), and cytotoxic T (Tc) cells. Th1 cells produce interferon-gamma (IFN-gamma) and activate macrophages to kill the yeast. Th2 cells produce interleukin-4 (IL-4) and IL-13, promoting B cell activation and antibody production. Th17 cells produce IL-17 and IL-22 and recruit neutrophils to the site of infection. Treg cells produce IL-10 and transforming growth factor-beta (TGF-beta), suppressing inflammation and tissue damage. Tc cells produce perforin and granzymes and directly kill infected cells. B cells are lymphocytes that produce antibodies that bind to Malassezia pachydermatis antigens and neutralize or opsonize them for phagocytosis.
Malassezia pachydermatis is a yeast that usually lives on the skin of animals, especially dogs, but can sometimes cause infections and diseases in humans. Some of the clinical manifestations of Malassezia pachydermatis related to humans are:
Fungemia: This is a bloodstream infection caused by M. pachydermatis, which in people with impaired immune systems can be fatal. It is frequently linked to the use of central venous catheters or intravenous infusions that contain lipids. Fever, chills, low blood pressure, and organ malfunction are possible symptoms.
Tinea versicolor: This benign skin condition caused by M. globosa, M. sympodialis, or M. furfur, closely related to M. pachydermatis. It is characterized by hypopigmented or hyperpigmented patches on the trunk, neck, arms, and face. The patches may be scaly, itchy, or asymptomatic.
Malassezia folliculitis: This is an inflammation of the hair follicles caused by Malassezia pachydermatis or another kind. It is manifested by pruritic papules and pustules on the chest, back, shoulders, arms, and face. It may resemble acne vulgaris or bacterial folliculitis.
Seborrheic dermatitis: This chronic inflammatory skin disorder affects the scalp, face, and chest. It is thought to be influenced by Malassezia species, including M. pachydermatis. It presents with erythema, scaling, and greasy, yellowish crusts on the affected areas. It may cause itching, burning, or irritation.
Malassezia pachydermatis can infect humans, particularly neonates and immunocompromised individuals. Diagnosis relies on clinical signs, blood culture (though limited), molecular methods like PCR, and histopathology. Clinical signs include fever, septic shock, respiratory distress, skin lesions, and organ dysfunction, but these are non-specific.
Blood culture is common but can be supplemented with molecular techniques for confirmation. Histopathology can visualize the yeast cells in tissues but can’t distinguish them from other fungi. Skin or ear samples can also be used but are less reliable for systemic infections.
Some general measures to control Malassezia pachydermatis infection are:
Removing or reducing the risk factors predisposing to infection, such as intravenous lipid supplementation, indwelling devices, immunosuppression, or skin barrier impairment.
Using topical or oral antifungal agents effective against Malassezia pachydermatis, such as ketoconazole, itraconazole, fluconazole, posaconazole, or amphotericin B.
Applying topical shampoos or creams that contain antifungal or anti-inflammatory ingredients, such as selenium sulfide, zinc pyrithione, coal tar, salicylic acid, or corticosteroids.
Cleaning and disinfecting the affected areas and avoiding scratching or rubbing.
Monitoring the clinical and microbiological response to treatment and adjusting the dose or duration of therapy accordingly.
The epidemiology of Malassezia pachydermatis is the study of the distribution and determinants of this yeast in different populations and environments. A zoophilic yeast called Malassezia pachydermatis typically dwells on the skin and ears of animals but can also cause infections in humans, especially neonates and immunocompromised patients.
Some of the factors that influence the epidemiology of Malassezia pachydermatis are:
The host species and their geographic location, Malassezia pachydermatis, has been isolated from various animals, such as dogs, cats, rhinoceroses, sea lions, and black bears. The prevalence and diversity of this yeast may vary depending on the animal species and their habitat. For example, a study found that M. pachydermatis was more prevalent and diverse in brown bears from Italy than in Finland.
The host’s health status and immune system Malassezia pachydermatis can cause opportunistic infections in hosts with impaired skin barrier function or immune system. It can be due to prematurity, malnutrition, malignancy, chemotherapy, organ transplantation, or HIV infection. Using intravenous lipid supplementation or parenteral nutrition via a catheter can also increase the risk of infection by providing a source of lipids for the yeast to grow and invade the bloodstream.
The transmission mode and environmental factors Malassezia pachydermatis can be spread from one animal to another, from an animal to a human, or from a human to another human. The transmission can occur through direct contact, indirect contact via fomites or vectors, or airborne dissemination. The growth and colonisation of this yeast on the skin can also be impacted by environmental variables including temperature, humidity, sebum production, or lipid content.
The molecular epidemiology of Malassezia pachydermatis is the study of the genetic variation and evolution of this yeast among different hosts and environments. Molecular typing methods such as intergenic-spacer 1 (IGS1) nucleotide sequence polymorphisms analysis or whole-genome sequencing it possible to determine the genotypes & subtypes of M. pachydermatis isolates and to investigate their phylogenetic relationships, clonal structure, and population dynamics.
Molecular epidemiology can help to understand the origin, spread, and transmission of M. pachydermatis infections and outbreaks in different settings, such as neonatal intensive care units (NICUs), veterinary clinics, or wildlife reserves. Molecular epidemiology can also help to identify potential risk factors, reservoirs, or sources of infection and to implement appropriate prevention and control measures.
Classification and Structure
Kingdom: Fungi
Phylum: Basidiomycota
Class: Malasseziomycetes
Order: Malasseziales
Family: Malasseziaceae
Genus:Malassezia
Species:M. pachydermatis
The structure of Malassezia pachydermatis can be summarized in five points as follows:
Shape and Lipid Dependency: Malassezia pachydermatis is a bottle-shaped yeast that does not depend on lipids for growth (non-lipid dependent).
Colony Characteristics: Colonies of Malassezia pachydermatis are typically cream or yellowish. They have a smooth to wrinkled texture and a convex shape with a slightly lobed margin.
Cell Shape and Size: The cells of Malassezia pachydermatis are ovoid (egg-shaped) in shape and have a size range of approximately 3.0–6.5 x 2.5 micrometers (μm).
Reproductive Mode: Colonies of Malassezia pachydermatis grow through unipolar budding, and the presence of hyphae (thread-like structures) in culture is rare.
Optimal Growth Conditions: The yeast species thrives at a temperature range of 30–37 °C, and it typically takes about five days for maturation to occur under these conditions
M. pachydermatis has been reported to have different antigenic types based on its cell wall composition and immunological properties. A study by Bond et al. (1995) identified four antigenic types of M. pachydermatis (A, B, C, and D) by using monoclonal antibodies and enzyme-linked immunosorbent assay (ELISA).
Another study by Bond et al. (1996) found that antigenic type A was the most prevalent among clinical isolates from dogs with otitis externa and dermatitis, followed by types B, C, and D. Antigenic type A was also associated with higher levels of phospholipase activity, which is an enzyme that can damage the host’s cell membranes.
More recently, a study by Cafarchia et al. (2013) used molecular methods to investigate the genetic diversity and antigenic types of M. pachydermatis from different animal hosts, including dogs, cats, horses, rabbits, bears, and bats. They found that M. pachydermatis had a high degree of genetic variability and could be divided into 12 genotypes based on the rDNA’s internal transcribed spacer (ITS) region.
They also found that the antigenic types A, B, C, and D corresponded to four main genotypes (I, II, III, and IV). In contrast, the other genotypes had mixed or undefined antigenic types. They suggested that the antigenic types of M. pachydermatis may reflect its adaptation to different hosts and environments.
Malassezia pachydermatis is a yeast that usually lives on the skin and ears of animals but can, in certain circumstances, infect humans. The pathogenesis of Malassezia pachydermatis related to humans is rare and mainly involves invasive infections in neonates or immunocompromised patients. Some of the factors that contribute to the pathogenesis are:
The use of intravenous lipid supplementation or parenteral nutrition via a catheter provides a source of lipids for the yeast to grow and invade the bloodstream.
A central venous catheter or other indwelling device is present. Endotracheal tubes, or peritoneal dialysis catheters, can act as a point of access for the yeast and cause biofilm formation.
The host immune system’s impairment can be due to prematurity, malnutrition, malignancy, chemotherapy, organ transplantation, or HIV infection.
The production of enzymes and metabolites by the yeast that damage the host tissues and cells, such as proteinase, phospholipase, hyaluronidase, and chondroitin-sulphatase.
Malassezia pachydermatis can cause septicemia, meningitis, endocarditis, peritonitis, pneumonia, and other systemic infections in humans. The diagnosis of Malassezia pachydermatis infection is based on clinical signs, blood culture, molecular methods, and histopathology.
The host defenses of Malassezia pachydermatis are the mechanisms the host’s immune system uses to protect itself from infection or colonization by this yeast. A commensal fungus called Malassezia pachydermatis typically dwells on the skin ofanimals, especially dogs, but can sometimes cause diseases such as otitis externa and dermatitis.
Some examples of innate defenses against Malassezia pachydermatis are:
Skin Barrier: The skin’s layers, including the tough epidermis with keratinocytes and melanocytes, act as a physical and chemical defense against microbial invasion.
Skin Microbiota: Diverse microorganisms on the skin create an ecosystem that competes with pathogens, produces antimicrobial substances, and influences the immune system.
Skin Immune System: Resident immune cells (e.g., Langerhans cells, macrophages) and recruited immune cells (e.g., neutrophils, lymphocytes) in the skin, along with various immune molecules recognize and respond to foreign invaders.
Some examples of adaptive defenses against Malassezia pachydermatis are:
Antigen-presenting cells (APCs), T cells, & B cells are used by the adaptive immune system to produce a targeted and persistent response to the yeast. APCs are immune cells that capture and process Malassezia pachydermatis antigens and present them to T cells. T cells are lymphocytes that differentiate into different subsets depending on the type of antigen and cytokine environment. T helper 1, T helper 17, & T helper 2 (Th1) are examples of T cell subsets, regulatory T (Treg), and cytotoxic T (Tc) cells. Th1 cells produce interferon-gamma (IFN-gamma) and activate macrophages to kill the yeast. Th2 cells produce interleukin-4 (IL-4) and IL-13, promoting B cell activation and antibody production. Th17 cells produce IL-17 and IL-22 and recruit neutrophils to the site of infection. Treg cells produce IL-10 and transforming growth factor-beta (TGF-beta), suppressing inflammation and tissue damage. Tc cells produce perforin and granzymes and directly kill infected cells. B cells are lymphocytes that produce antibodies that bind to Malassezia pachydermatis antigens and neutralize or opsonize them for phagocytosis.
Malassezia pachydermatis is a yeast that usually lives on the skin of animals, especially dogs, but can sometimes cause infections and diseases in humans. Some of the clinical manifestations of Malassezia pachydermatis related to humans are:
Fungemia: This is a bloodstream infection caused by M. pachydermatis, which in people with impaired immune systems can be fatal. It is frequently linked to the use of central venous catheters or intravenous infusions that contain lipids. Fever, chills, low blood pressure, and organ malfunction are possible symptoms.
Tinea versicolor: This benign skin condition caused by M. globosa, M. sympodialis, or M. furfur, closely related to M. pachydermatis. It is characterized by hypopigmented or hyperpigmented patches on the trunk, neck, arms, and face. The patches may be scaly, itchy, or asymptomatic.
Malassezia folliculitis: This is an inflammation of the hair follicles caused by Malassezia pachydermatis or another kind. It is manifested by pruritic papules and pustules on the chest, back, shoulders, arms, and face. It may resemble acne vulgaris or bacterial folliculitis.
Seborrheic dermatitis: This chronic inflammatory skin disorder affects the scalp, face, and chest. It is thought to be influenced by Malassezia species, including M. pachydermatis. It presents with erythema, scaling, and greasy, yellowish crusts on the affected areas. It may cause itching, burning, or irritation.
Malassezia pachydermatis can infect humans, particularly neonates and immunocompromised individuals. Diagnosis relies on clinical signs, blood culture (though limited), molecular methods like PCR, and histopathology. Clinical signs include fever, septic shock, respiratory distress, skin lesions, and organ dysfunction, but these are non-specific.
Blood culture is common but can be supplemented with molecular techniques for confirmation. Histopathology can visualize the yeast cells in tissues but can’t distinguish them from other fungi. Skin or ear samples can also be used but are less reliable for systemic infections.
Some general measures to control Malassezia pachydermatis infection are:
Removing or reducing the risk factors predisposing to infection, such as intravenous lipid supplementation, indwelling devices, immunosuppression, or skin barrier impairment.
Using topical or oral antifungal agents effective against Malassezia pachydermatis, such as ketoconazole, itraconazole, fluconazole, posaconazole, or amphotericin B.
Applying topical shampoos or creams that contain antifungal or anti-inflammatory ingredients, such as selenium sulfide, zinc pyrithione, coal tar, salicylic acid, or corticosteroids.
Cleaning and disinfecting the affected areas and avoiding scratching or rubbing.
Monitoring the clinical and microbiological response to treatment and adjusting the dose or duration of therapy accordingly.
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Digital Certificate PDF
On course completion, you will receive a full-sized presentation quality digital certificate.
medtigo Simulation
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
medtigo Points
medtigo points is our unique point redemption system created to award users for interacting on our site. These points can be redeemed for special discounts on the medtigo marketplace as well as towards the membership cost itself.
Community Forum post/reply = 5 points
*Redemption of points can occur only through the medtigo marketplace, courses, or simulation system. Money will not be credited to your bank account. 10 points = $1.
All Your Certificates in One Place
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
